DXCM vs TBI · P/E 63, rev $2.50B vs rev $841.6M
DexCom Inc (DXCM) versus TrueBlue Inc (TBI) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
TrueBlue Inc (TBI) is a staffing & employment services company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported TBI revenue for 2026-06-28 was $841.6M. Net income was -$23.2M. TBI currently screens at market cap $205.8M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. TBI currently screens at market cap $205.8M.
Not investment advice. Open the DXCM and TBI stock pages for the full models.
Not investment advice.